Trial Profile

A multicenter, phase II, randomized, controlled trial evaluating the efficacy and safety of sunitinib in combination with bevacizumab and paclitaxel in previously untreated patients with metastatic breast cancer

Status: Discontinued

Phase of Trial: Phase II

Latest Information Update: 10 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

23 May 2010 Results published in the Annals of oncology : official journal of the European Society for Medical Oncology (ESMO).
01 Dec 2007 The expected completion date for this trial is now 1 Oct 2010.
28 Mar 2007 Status changed from initiated to recruiting.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com